SCHEMBL8246455

SCHEMBL8246455

CCCC[C@H](C)CCNCCC

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 4/20 0.42
ALDH1A1 P00352 3/20 0.42
DNM1 Q05193 2/20 0.39
CYP3A4 P08684 1/20 0.38
ACE2 Q9BYF1 1/20 0.36
LMNA P02545 1/20 0.35
PAOX Q6QHF9 1/20 0.34
SLC15A1 P46059 1/20 0.34
CA1 P00915 2/20 0.33
CA2 P00918 2/20 0.33
ADH1B P00325 2/20 0.33
ADH1C P00326 2/20 0.33
ADH1A P07327 2/20 0.33
ADH7 P40394 2/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
ADH4 P08319 1/20 0.33
OPRM1 P35372 1/20 0.32
MEN1 O00255 1/20 0.31
GLA P06280 1/20 0.31
CYP2C19 P33261 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19774502 0.96 TSHR (0.44) TSHRALDH1A1DNM1CYP3A4ACE2
SCHEMBL4317793 0.95 TSHR (0.46) TSHRALDH1A1DNM1CYP3A4ACE2
SCHEMBL22854544 0.91 ACE2 (0.47) TSHRALDH1A1DNM1ACE2LMNA
SCHEMBL22701029 0.91 ACE2 (0.47) TSHRALDH1A1DNM1ACE2LMNA
SCHEMBL24673884 0.91 ACE2 (0.47) TSHRALDH1A1DNM1ACE2LMNA
SCHEMBL14547173 0.88 ALDH1A1 (0.41) TSHRALDH1A1DNM1CYP3A4ACE2
SCHEMBL10596435 0.86 CA12 (0.43) TSHRALDH1A1DNM1CYP3A4ACE2
SCHEMBL7109086 0.86 TSHR (0.52) TSHRALDH1A1DNM1CYP3A4ACE2
SCHEMBL18388567 0.85 TSHR (0.42) TSHRALDH1A1PAOXADH1BADH1A
SCHEMBL8125049 0.85 TSHR (0.42) TSHRALDH1A1PAOXADH1BADH1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2336136-A1 Pyridine derivatives and their use in the treatment of psychotic disorders GlaxoSmithKline LLC (US) 2011-06-22 EP disclosed
WO-2007028654-A1 PYRIDINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF PSYCHOTIC DISORDERS SMITHKLINE BEECHAM CORPORATION (US) 2007-03-15 WO disclosed